Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies.
about
Changes in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroidsGlycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor GrowthNanomedicine therapeutic approaches to overcome cancer drug resistanceCharacterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell deathMolecular profiling of platinum resistant ovarian cancer.The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck.The Role of PI3K Isoforms in Regulating Bone Marrow Microenvironment Signaling Focusing on Acute Myeloid Leukemia and Multiple Myeloma.Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β.Tumorigenic potential and disease manifestations of malignant B-cell variants differing in their fibronectin adhesivenessEvidence of a role for activation of Wnt/beta-catenin signaling in the resistance of plasma cells to lenalidomide.Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-induced cell death.MGr1-Ag/37LRP induces cell adhesion-mediated drug resistance through FAK/PI3K and MAPK pathway in gastric cancer.Integrins and extracellular matrix: a novel mechanism of multidrug resistance.Down-regulation of CD9 by methylation decreased bortezomib sensitivity in multiple myeloma.Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death.Treatment of mantle cell lymphoma: targeting the microenvironment.Extracellular matrix in bone marrow can mediate drug resistance in myeloma.BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic Escape.The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death.Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems.Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance.Novel strategies for reversing platinum resistance.Mechanisms of resistance to photodynamic therapy.Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.Membrane drug transporters and chemoresistance in human pancreatic carcinoma.Molecularly targeted therapies in multiple myelomaThe role of cytoskeleton and adhesion proteins in the resistance to photodynamic therapy. Possible therapeutic interventions.Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab.The role of ubiquitin-specific protease 14 (USP14) in cell adhesion-mediated drug resistance (CAM-DR) of multiple myeloma cells.Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma.RANK-RANKL interactions are involved in cell adhesion-mediated drug resistance in multiple myeloma cell lines.Inhibition of human 67-kDa laminin receptor sensitizes multidrug resistance colon cancer cell line SW480 for apoptosis induction.Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma.Maspin influences response to doxorubicin by changing the tumor microenvironment organization.Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells.
P2860
Q24812918-909E0014-D4DB-4440-BDE7-DCD906C2C010Q26742115-A5B2EBDE-605B-4A56-8BB9-17F59EDAB6F6Q26774159-1D669CFD-9C59-4C04-A683-C00AE5B118A1Q27011692-F73AB76C-BA09-4CF5-85C8-0DD836356FB8Q28482928-0ADCB43D-A0D6-4AEF-A72F-581086A2B75CQ33227163-14599E73-4E25-4155-A80F-E97FAE144012Q33489630-2CF573BE-6835-4CD8-96AE-4E6E1F03269FQ33607950-8D096277-E761-4EBF-BDE4-3E74F285530CQ33889679-47A6B447-FA91-49BA-9146-D903E2FC2701Q34289029-1781B3F9-191F-4C25-B759-150B02B562DCQ34719436-BA1B351A-F129-4E3A-9C84-400C4464D04DQ35024449-D21EF391-FF53-42CD-A443-AACFE295B079Q35051795-98E4A173-C04A-4BEC-8D31-891FF674F7DBQ35089143-BCC5BE19-4910-4AC8-9590-9A588E068739Q35161600-262FEE0B-099B-452A-941C-C2234C566A08Q35567260-5AF1AEC2-8BB7-4DD1-B1CA-C7878DCC012CQ36185624-2E70985A-7523-4FA8-9F2A-8ED83E6B67E9Q36194659-F3E57445-4AEF-4547-B8E1-BA9300E9092FQ36289114-6719ED91-688F-4CF0-96B3-4E879040405DQ36445818-7B5D4A99-E1CF-4A48-9CD2-1BFF09AF966AQ36454748-22975F6C-49B3-4CC3-ABE2-CD3C34482B8BQ36976151-A806352B-1B6A-42FB-8FEF-0F6ED8048078Q37007099-ED3440BC-CC7F-4F63-AF43-46974D68514BQ37149205-9C777C2F-1AFB-4BA8-9B21-82C57AD9F5C5Q37461061-1E0A43FB-E2C6-47E7-B89E-92C68C47932BQ37875160-1D141869-3E74-445C-A56A-D6A85E1F5F00Q37973062-5848CF1E-562D-4305-A28E-592E5CAB60A4Q38161328-2AE1DAC0-CFC8-43F8-919C-0CC9A0DE0076Q38211866-412EACD8-1696-419D-9FD3-6BA9213523E6Q38400490-A2EF9AA3-BEE0-42A5-B91B-B9DEC0073DBFQ38661370-CF8E49AF-DEFB-4658-9E7E-1FCD93B4693DQ38734491-46B353E3-AA3A-4C97-A6B4-9A53CEFF7BE8Q38763444-B9F22B19-9648-461C-8C98-C47BAC9AA2F8Q38804090-4307D46E-36A5-4C05-8B17-E0BCA953CC90Q38842157-ECF5BA63-3C44-49BC-8B8E-035245A4485DQ38862089-5411302A-4E58-44AF-A624-31C1C44CC660Q38895636-EA786A06-7ED7-460A-8B43-22D4D9F6B908Q39048563-99F2DC78-E440-4A64-A237-9E450E58E10AQ39062271-8A19335A-4A87-40CE-B970-E9F052FD3639Q39068932-84DBBE69-D2EC-4327-AD05-49C57F4A8247
P2860
Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Mechanisms associated with cel ...... in hematopoietic malignancies.
@ast
Mechanisms associated with cel ...... in hematopoietic malignancies.
@en
Mechanisms associated with cell adhesion mediated drug resistance
@nl
type
label
Mechanisms associated with cel ...... in hematopoietic malignancies.
@ast
Mechanisms associated with cel ...... in hematopoietic malignancies.
@en
Mechanisms associated with cell adhesion mediated drug resistance
@nl
prefLabel
Mechanisms associated with cel ...... in hematopoietic malignancies.
@ast
Mechanisms associated with cel ...... in hematopoietic malignancies.
@en
Mechanisms associated with cell adhesion mediated drug resistance
@nl
P356
P1476
Mechanisms associated with cel ...... in hematopoietic malignancies.
@en
P2093
Hazlehurst LA
P2888
P356
10.1023/A:1013156407224
P577
2001-01-01T00:00:00Z
P6179
1031806834